Basic Levitra With Dapoxetine Information

• INN (International Nonproprietary Name): Vardenafil with Dapoxetine. Vardenafil treats erectile dysfunction (ED). Dapoxetine treats premature ejaculation (PE).
• Brand Names Available In Canada (English): Super Levitra; Levitra With Dapoxetine; Vardenafil+Dapoxetine; Super Vilitra. Common pack formats: film‑coated tablets labelled 20 mg/60 mg or 40 mg/60 mg in blisters of 4, 10, or 20 tablets.
• ATC Code: Vardenafil — G04BE09. Dapoxetine — G04BX14. Forms & dosages: film‑coated tablets 20 mg vardenafil + 60 mg dapoxetine, and 40 mg vardenafil + 60 mg dapoxetine. Manufacturers listed in international markets include Sunrise Remedies, Centurion Laboratories and various private‑label exporters.

Critical Warnings & Restrictions In Canada

Immediate Patient Protection & Health Canada Context

The fixed‑dose combination of vardenafil + dapoxetine carries high‑risk interactions and clinical contraindications that require careful screening.

There is no widely recognised Health Canada marketing authorisation or DIN for a fixed‑dose vardenafil+dapoxetine product.

Prescribing or sourcing must follow Canadian regulatory safeguards: prescription only, pharmacist verification and heightened counselling.

• Absolute Contraindications: concurrent nitrate therapy; known hypersensitivity to either agent; moderate to severe hepatic or renal impairment; recent myocardial infarction or stroke; severe heart failure; concomitant SSRIs, MAOIs or thioridazine; age under 18.
• Relative Contraindications/High Risk Interactions: strong CYP3A4 inhibitors; alpha‑blockers; significant arrhythmias; predisposition to priapism; uncontrolled hypertension.

Patients must disclose cardiac history, current medications (including over‑the‑counter nitrates and herbal products), hepatic/renal impairment and psychiatric history before initiating therapy.

Urgent care signs that require immediate assessment are listed below.

• Chest pain or pressure.
• Fainting or sudden severe dizziness.
• Priapism (erection lasting more than 4 hours).
• Severe shortness of breath or palpitations.
• Confusion, high fever, tremor, or rigid muscles suggesting serotonin syndrome.

High‑Risk Groups

Elderly patients have an increased risk of orthostatic hypotension and dizziness and should start at the lowest available dose.

Elderly

Start low; monitor blood pressure and orthostatic symptoms.

Pregnancy and Breastfeeding

Dapoxetine has not been studied in pregnancy or lactation; the product is not indicated for women and contraception/avoidance should be discussed where relevant.

Indigenous And Marginalised Populations

Offer culturally safe counselling, plain language materials and translator or Indigenous health liaison services when available.

Document informed consent and provide printed take‑home safety sheets in English and French as required.

Baseline screening checklist for high‑risk patients:

• ECG to assess arrhythmia or ischemia risk.
• Liver function tests and renal function.
• Cardiovascular risk assessment (history of MI, stroke, uncontrolled hypertension).

Interaction With Activities

Dizziness, blurred vision or syncope may impair driving or the safe operation of machinery.

Under provincial workplace safety rules and the Criminal Code regarding impaired operation, patients must avoid driving until they know how the medicine affects them.

Alcohol increases the risk of hypotension and sedation and may worsen dapoxetine‑related nausea or sleep disturbance.

If work is safety‑sensitive, patients should consult occupational health before using the combination; employer disclosure is only recommended when safety is directly affected.

Q&A — Can I Drive After Taking It In Canada?

Q: Can I drive after taking vardenafil+dapoxetine?

A: Avoid driving if you experience dizziness, visual changes, excessive drowsiness or syncope after taking the tablet.

A: Wait until effects have worn off and you can judge personal tolerance; follow provincial occupational safety guidance for safety‑sensitive work.

Usage Basics For Canadians

INN, Brand Names Available In Canada

INN: Vardenafil with Dapoxetine (vardenafil + dapoxetine).

International product labels commonly read Super Levitra, Levitra With Dapoxetine, Vardenafil+Dapoxetine and Super Vilitra.

These fixed‑dose products are marketed mainly in non‑Western regions and via online pharmacies rather than through Health Canada authorisations.

• Super Levitra — often shown as 20 mg/60 mg film‑coated tablets.
• Levitra With Dapoxetine — alternate labeling in some online listings.
• Super Vilitra — manufacturer examples from India.

Legal Classification Under Health Canada

The fixed‑dose vardenafil+dapoxetine combination is prescription‑only in most jurisdictions and should be treated as Rx in Canada.

Importing prescription drugs for personal use is restricted; seek a Canadian prescriber’s approval and pharmacist verification and confirm product legitimacy.

1. Obtain a valid prescription from a Canadian prescriber.
2. Request pharmacist verification of product and packaging on arrival.
3. Keep records of manufacturer, lot and expiry for inspection or adverse event reporting.

Canadian Dosing Guide

Standard Regimens

Typical fixed‑dose strengths sold internationally are 20 mg vardenafil + 60 mg dapoxetine and 40 mg vardenafil + 60 mg dapoxetine.

Dosing is on‑demand: take one tablet 30–60 minutes before sexual activity, with a maximum of one tablet per 24 hours.

Because this fixed combination lacks broad Health Canada approval, Canadian prescribers may initiate evidence‑based monotherapy first (vardenafil or dapoxetine) and document the rationale before considering off‑label fixed combos.

• Start at the lowest available dose in elderly patients.
• Consider starting with vardenafil 20 mg where possible and adjust based on response and tolerability.

Adjustments For Comorbidities

Moderate to severe hepatic or renal impairment is contraindicated for the fixed combination.

Diabetes increases the prevalence of ED; screen cardiovascular risk before initiating any PDE5 inhibitor in diabetic patients.

For patients on CYP3A4 inhibitors (such as some antiretrovirals) reduce dose or avoid due to increased vardenafil exposure.

Monitor blood pressure and mental health in patients with depression or those already taking antidepressants.

Q&A — What If I Miss A Dose Under My Provincial Drug Plan?

Q: If I miss a dose, can I take it later or claim under my provincial plan?

A: This product is on‑demand; if you miss a planned dose, skip it and do not double up.

A: Provincial coverage requires a valid DIN and formulary listing; imported fixed combos are unlikely to be reimbursable. Contact your provincial drug plan and pharmacist for specific exceptions.

• Call your provincial drug plan customer service.
• Ask your pharmacist whether the product carries a DIN and is on the formulary.

Interaction Chart (Canadian Context)

Food And Drinks

Alcohol increases dizziness, hypotension and may exacerbate dapoxetine‑related nausea and sedation.

Grapefruit juice inhibits CYP3A4 and may raise vardenafil concentrations; avoid grapefruit or large amounts around dosing.

Caffeine can worsen anxiety or insomnia that might be related to dapoxetine.

• Timing tip: allow 30–60 minutes after dosing before sexual activity; avoid heavy meals and alcohol near dosing times.

Common Drug Conflicts

Key drug conflicts include nitrates (absolute contraindication), SSRIs/MAOIs/thioridazine (serotonin syndrome and arrhythmia risk), strong CYP3A4 inhibitors and alpha‑blockers.

• Perform medication reconciliation at every visit and flag OTC nitrates such as some topical chest sprays or herbal vasodilators.
• Ask specifically about recreational substances and herbal supplements that may affect CYP enzymes.

User Reports & Trends In Canada

Canadian Patient Forums And Review Platforms

Online Canadian forums and communities show interest in combined ED+PE therapy but frequent caution about sourcing imported fixed combos.

Common patient concerns are price, authenticity, side effects like dizziness or sleep disruption, and the lack of local regulatory approval.

• Top concerns: authenticity, cost, side effects, and legal coverage.
• Advice: triangulate forum reports with Health Canada guidance, provincial health lines and pharmacy verification.

Community Pharmacy Feedback

Community pharmacists report that combined vardenafil+dapoxetine tablets are uncommon in domestic stock.

Pharmacists dispense single‑entity PDE5 inhibitors or dapoxetine where available and screen for nitrates and interactions.

• Document counselling and provide patient information leaflets in English and French.
• Key counselling points: contraindications, driving and alcohol advice, when to seek urgent care.

Access & Purchase Options

National Pharmacy Chains

Major Canadian pharmacy chains stock Health Canada‑approved products with DINs and typically do not stock the fixed‑dose combo without a DIN.

Patients should consult a primary care provider or sexual health clinic to discuss legally prescribable alternatives.

• At national chains: bring a prescription, ask for DIN verification and request printed counselling materials.
• Ask the pharmacist about therapeutic alternatives that are Health Canada‑authorised.

Online Pharmacies In Canada & Provincial Restrictions

Many international e‑pharmacies advertise Super Levitra or Super Vilitra from India or China, but these products may lack Health Canada authorisation.

Personal import rules allow limited emergency supplies but products without a DIN are unlikely to be reimbursed and carry authenticity risk.

1. Check for CIPA or other Canadian pharmacy certifications.
2. Confirm prescriber confirmation and hold on to lot/expiry labels on arrival.

Mechanism & Pharmacology

Simplified Explanation

Vardenafil is a phosphodiesterase‑5 (PDE5) inhibitor that increases penile blood flow to treat erectile dysfunction.

Dapoxetine is a short‑acting selective serotonin reuptake inhibitor designed to delay ejaculation.

Combined, the agents aim to improve erection quality and prolong ejaculatory latency.

• Onset: vardenafil 30–60 minutes; dapoxetine contributes central delay in ejaculation within similar timing.

Suggestion: include an infographic in patient handouts showing timing and key warnings.

Clinical Terms

ATC Codes

Vardenafil — G04BE09; Dapoxetine — G04BX14.

Pharmacokinetics Highlights

Both drugs are metabolised via CYP pathways; vardenafil principally by CYP3A4 and dapoxetine by mixed CYP enzymes — interactions with CYP inhibitors are clinically relevant.

Reference Health Canada monographs for single‑agent vardenafil and dapoxetine when counselling patients.

Indications & Off‑Label Uses In Canada

Approved Indications (DIN)

Vardenafil as a single agent is indicated for erectile dysfunction in jurisdictions where authorised.

Dapoxetine is indicated for premature ejaculation where authorised, but its Canadian availability and DIN status may be limited.

The fixed‑dose combination lacks a widely recognised Canadian DIN and is not routinely authorised for sale in Canada.

• Clinicians should base treatment on diagnosis: ED, PE, or both, and consider single‑agent therapy first.

Common Off‑Label Practices

Some clinicians prescribe both drugs concurrently off‑label or document informed consent for imported fixed combos when clinically justified.

1. Document medical rationale for combined therapy in the chart.
2. Obtain written informed consent explaining risks like serotonin syndrome, hypotension and priapism.
3. Set a monitoring plan for adverse events and follow‑up.

Key Clinical Findings

Canadian And International Studies 2022–2025

Recent international trials show improved erectile function and ejaculatory latency with combined PDE5 inhibitor plus dapoxetine in selected populations.

Heterogeneity in study design and limited Western regulatory approvals mean clinicians must appraise applicability to Canadian patients, who may have higher diabetes and cardiovascular disease prevalence.

• Primary endpoints to review: IIEF (erectile function), IELT (intravaginal ejaculatory latency time), adverse event rates.

No major Health Canada‑sponsored trials for the fixed combination were publicly documented in the supplied data.

Ongoing Health Canada Safety Monitoring

Report adverse events to Canada Vigilance, particularly serious reactions such as priapism, syncope, chest pain, serotonin syndrome or suspected counterfeit products.

1. Collect product details (manufacturer, lot, expiry).
2. Report via Canada Vigilance online or by phone.
3. Notify local public health if counterfeit medication is suspected.

Alternatives Matrix

Comparable Medicines With DIN In Canada

Alternatives include single‑entity PDE5 inhibitors that often carry Canadian DINs: sildenafil, tadalafil and in some cases vardenafil single‑agent products.

Dapoxetine (Priligy) may not have widespread Canadian availability; check current DIN status before prescribing.

• Decision factors: cardiac risk, drug interactions, patient preference, cost and coverage.

Pros And Cons Checklist

• Pros: Single tablet convenience for combined ED and PE; potential improved satisfaction for comorbid cases.
• Cons: Increased interaction risk, off‑label status in Canada, likely non‑reimbursable, counterfeit risk when imported.

Recommend a stepwise approach: treat the dominant condition first, reassess response and tolerance, then consider combination therapy with specialist guidance if needed.

Common Questions From Canadian Patients

• Is it safe to drink alcohol with the tablet? — Limit or avoid alcohol due to hypotension and sedation risk.
• Can I take it with my antidepressant? — Combining with SSRIs/MAOIs increases serotonin syndrome risk; consult your prescriber.
• How do I check authenticity? — Verify manufacturer, lot, expiry and buy from CIPA‑certified Canadian pharmacies where possible.
• Is import legal? — Personal import rules are restricted; a Canadian prescription and verification are advised.
• When does it start working and how long? — Typically 30–60 minutes onset; single‑dose effects vary and should not be repeated within 24 hours.
• What do I do with side effects? — Stop the drug and seek medical advice for severe symptoms such as chest pain or prolonged erection; report serious events to Canada Vigilance.
• Will my provincial plan cover it? — Fixed combos without DIN are generally not covered; check with your provincial formulary.
• Is it recreational? — Not recommended for recreational use or by persons without diagnosed sexual dysfunction disorders.
• What are common mild side effects? — Headache, flushing, dizziness, nasal congestion, nausea and insomnia.
• Who should I tell at work? — Only disclose occupationally relevant effects for safety‑sensitive roles and consult occupational health.

Suggested flowchart for patients: symptom or concern → stop drug if severe → contact prescriber/pharmacist → urgent care for chest pain or priapism.

Coverage & Purchase Comparison Table

Comparison Table — Province/Plan

Fixed‑dose combos without a DIN are generally not covered by provincial plans such as Ontario Drug Benefit, BC PharmaCare or RAMQ.

For accurate plan coverage and pricing, check provincial formularies and pharmacy price lists.

Checklist for reimbursement application:

1. Confirm DIN and product monograph.
2. Request special authorisation if clinically justified.
3. Provide supporting clinical documentation and informed consent.

Step‑By‑Step Purchase Checklist For Canadian Patients

1. See your primary care clinician or sexual health clinic for assessment.
2. Obtain a prescription that documents the diagnosis and rationale.
3. Ask the pharmacist for DIN and brand information.
4. Verify product authenticity on arrival — keep packaging and lot numbers.
5. Confirm coverage with your provincial drug plan before purchase.
6. Avoid unverified international sites and unlabelled products.
7. Keep counselling documentation and follow‑up plans.

Registration & Regulation

Health Canada Approval

The fixed‑dose vardenafil+dapoxetine combination is not centrally authorised by many Western regulators and there is no widely documented Health Canada marketing authorisation or DIN for fixed combos in the supplied data.

Routine stocking and reimbursement are therefore unlikely.

• Clinicians should follow import rules, document rationale for off‑label or imported use and advise patients about legal and insurance implications.
• Keep a copy of the prescription and product documentation for inspection and adverse event reporting.

DIN Number And Labelling Requirements

Only products with a valid DIN on a Canadian label are eligible for provincial formulary listing.

Quebec shipments require bilingual labelling on products that enter provincial distribution.

• Verify the DIN on the physical packaging and retain the outer packaging for records.
• When importing, keep all labelling and invoices for potential inspection.

Storage & Handling

Standard Canadian Household Conditions

Store tablets below 30 °C (86 °F), away from moisture, heat and direct light.

Keep medication in the original packaging and avoid storing in bathrooms or cars where temperature and humidity fluctuate.

Secure storage away from children and pets and check expiry dates before use.

• Home storage checklist: original blister, dry place, under 30 °C, out of reach of children.

Cold‑Chain Requirements (Where Applicable)

Film‑coated tablets do not require cold‑chain storage per the supplied data.

When receiving imported shipments, inspect packaging for heat or moisture damage and document any concerns in the pharmacy temperature logs.

1. Inspect incoming parcels for intact seals and undamaged blister packs.
2. Record lot numbers and receipt temperatures where possible.

Guidelines For Proper Use

Canadian Pharmacist Guidance

Pharmacists should perform a full medication review, verify prescription authenticity and screen specifically for nitrates and serotonergic agents.

Counsel on side effects including dizziness, visual changes, gastrointestinal upset and insomnia, and advise on driving and alcohol avoidance.

• Document counselling, record lot/expiry for imported products and inform the patient about lack of DIN and reimbursement implications.

Suggested patient leaflet headings: What This Medicine Does; How To Take It; Important Safety Information; When To Seek Emergency Care; Storage Instructions; Questions For Your Pharmacist.

Provincial Health Authority Recommendations

Follow provincial sexual health and cardiovascular guidelines when initiating PDE5 inhibitors or dapoxetine.

Escalate complex cases to urology or sexual medicine specialists and enroll patients in post‑market surveillance if available.

1. Follow‑up timeline: initial review at 2–4 weeks for tolerability, then at 3 months for efficacy and cardiovascular reassessment.
2. Referral triggers: recurrent syncope, chest pain, priapism, severe psychiatric symptoms or suspected counterfeit product.

Delivery Across Canada (English)

Closing Practical Notes

This fixed‑dose combination is frequently sourced online and marketed under names such as Super Levitra and Super Vilitra.

Clinicians and pharmacists must verify the product, document informed consent for off‑label or imported use and report adverse events through Canada Vigilance.

When prescribing, document why single‑agent therapy was insufficient or why combination therapy is clinically justified and plan follow‑up for safety monitoring.

For patients: always bring a complete medication list, avoid nitrates and large amounts of alcohol, and seek urgent care for chest pain, syncope or priapism.

For reimbursement or formulary questions, contact your provincial drug plan and retain all packaging and prescription documentation for appeals or special authorisation requests.